Physician profile
Eduardo Estrella
NPI 1316988660
$26,318.06
in general payments reported to CMS, 2019-2025
14 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $8,200 · 2022: $122 · 2023: $1,003 · 2024: $132 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Travel and Lodging: $53.46 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Travel and Lodging | $53.46 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19,958.52 | 2019-2020 | |
| Boston Scientific Corporation | $4,668.97 | 2019-2020 | |
| Minerva Surgical, INC | $867.78 | 2023 | |
| Hologic Sales and Service, LLC | $258.86 | 2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Meditrina | $237.69 | 2022-2025 | |
| Organon LLC | $131.67 | 2024 | |
| Astellas Pharma US INC | $71.99 | 2022 | |
| Applied Medical Resources Corporation | $21.21 | 2022 | |
| Smith+Nephew, INC. | $17.92 | 2019 | |
| Pfizer INC. | $17.44 | 2023 | |
| Therapeuticsmd, INC. | $17.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.62 | 2025 | |
| Daiichi Sankyo INC. | $16.14 | 2019 | |
| Allergan, INC. | $16.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Estrella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.